
SEPTEMBER 2, 2026
Health Care’s Next Act: Tailwinds Emerging Across R&D Cycle
ClearBridge Investments: Drug development appears to be stabilizing, as improving biopharma funding and healthier demand create a more constructive backdrop for contract research organizations and lif...







